# Desensitization With Bortezomib Before a Living Kidney Donation

> **NCT01842074** · PHASE4 · UNKNOWN · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 10 (estimated)

## Conditions studied

- Patients Awaiting a Living Kidney Donation

## Interventions

- **DRUG:** Bortezomib

## Key facts

- **NCT ID:** NCT01842074
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-03
- **Primary completion:** 2017-03
- **Final completion:** 2018-03
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2016-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01842074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01842074, "Desensitization With Bortezomib Before a Living Kidney Donation". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT01842074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*